These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16829648)

  • 1. Measures of response: RECIST, WHO, and new alternatives.
    Jaffe CC
    J Clin Oncol; 2006 Jul; 24(20):3245-51. PubMed ID: 16829648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiological evaluation of tumor response in oncological studies (tumor response evaluation)].
    Gebauer B; Bohnsack O; Riess H
    Rofo; 2011 Aug; 183(8):695-703. PubMed ID: 21391174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
    Lencioni R; Llovet JM
    Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
    Stacchiotti S; Collini P; Messina A; Morosi C; Barisella M; Bertulli R; Piovesan C; Dileo P; Torri V; Gronchi A; Casali PG
    Radiology; 2009 May; 251(2):447-56. PubMed ID: 19261927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer treatment response evaluation based on imaging modalities, such as computed tomography, magnetic resonance imaging and FDG-PET].
    Endo M; Aramaki T; Moriguchi M; Sawada A; Asakura K; Bekku E
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):294-8. PubMed ID: 23507590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography/computed tomography.
    Townsend DW
    Semin Nucl Med; 2008 May; 38(3):152-66. PubMed ID: 18396176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in paediatric tumour imaging.
    Moon L; McHugh K
    Arch Dis Child; 2005 Jun; 90(6):608-11. PubMed ID: 15908626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group.
    Schwartz LH; Seymour L; Litière S; Ford R; Gwyther S; Mandrekar S; Shankar L; Bogaerts J; Chen A; Dancey J; Hayes W; Hodi FS; Hoekstra OS; Huang EP; Lin N; Liu Y; Therasse P; Wolchok JD; de Vries E
    Eur J Cancer; 2016 Jul; 62():138-45. PubMed ID: 27237360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of response criteria for clinical trials of sarcoma treatment.
    Schuetze SM; Baker LH; Benjamin RS; Canetta R
    Oncologist; 2008; 13 Suppl 2():32-40. PubMed ID: 18434637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor response evaluation in oncology: current update.
    Shanbhogue AK; Karnad AB; Prasad SR
    J Comput Assist Tomogr; 2010 Jul; 34(4):479-84. PubMed ID: 20657213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements.
    Cohade C; Wahl RL
    Semin Nucl Med; 2003 Jul; 33(3):228-37. PubMed ID: 12931324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.
    Mankoff DA; Eary JF; Link JM; Muzi M; Rajendran JG; Spence AM; Krohn KA
    Clin Cancer Res; 2007 Jun; 13(12):3460-9. PubMed ID: 17575208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of time-of-flight PET on quantification errors in MR imaging-based attenuation correction.
    Mehranian A; Zaidi H
    J Nucl Med; 2015 Apr; 56(4):635-41. PubMed ID: 25745090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.
    Desar IM; van Herpen CM; van Laarhoven HW; Barentsz JO; Oyen WJ; van der Graaf WT
    Cancer Treat Rev; 2009 Jun; 35(4):309-21. PubMed ID: 19136215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-assisted image analysis of bronchioloalveolar carcinoma.
    Lau D; Seibert A; Gandara D; Laptalo L; Geraghty E; Coulon C
    Clin Lung Cancer; 2005 Mar; 6(5):281-6. PubMed ID: 15845178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging and alignment for image-guided radiation therapy.
    Balter JM; Kessler ML
    J Clin Oncol; 2007 Mar; 25(8):931-7. PubMed ID: 17350941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuously moving table MRI in oncology.
    Schaefer AO; Langer M; Baumann T
    Rofo; 2010 Nov; 182(11):954-64. PubMed ID: 20922644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular imaging in cancer therapy].
    Weber WA
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):810-7. PubMed ID: 20700780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.